The On-Body Drug Delivery Devices market is witnessing significant growth, driven by the increasing demand for ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer ...

DETECTIVES investigating reports of spiking in west Cumbria have found no evidence of drugs present or any suspicious behaviour.

CEO Brian Lian highlighted 2024 as an exceptionally busy year, with successful results from four studies, including the Phase 2 VENTURE trial for subcutaneous VK2735, which demonstrated up to 14.7% ...

ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

At MD&M West, PIA will give attendees live demonstrations of its assembly technology, including V-RAC. In Booth 5328 in the ...

Q3 2024 Earnings Call Transcript February 10, 2025 Roivant Sciences Ltd. beats earnings expectations. Reported EPS is $0.23, expectations were $-0.24. Operator: Ladies and gentlemen, thank you for ...

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...

The US Food and Drug Administration (FDA) classified this as a Class 1 recall, meaning the product posed a serious health ...

Staying in one lane doesn’t work for women like Dr. Joanna Sawyer, who has designed a smartwatch to help save the lives of ...

Jabil acquires Pharmaceutics International to enhance commercial prospects in the emerging market of CDMO services.